Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1976 May;69(5):375–377. doi: 10.1177/003591577606900534

W E Dixon Memorial Lecture. Beta-adrenoceptor blockade in hyperthyroidism and anxiety.

P Turner
PMCID: PMC1864263  PMID: 5736

Full text

PDF
375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOWMAN W. C., ZAIMIS E. The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat. J Physiol. 1958 Nov 10;144(1):92–107. doi: 10.1113/jphysiol.1958.sp006088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bonn J. A., Turner P. D-Propranolol and anxiety. Lancet. 1971 Jun 26;1(7713):1355–1356. doi: 10.1016/s0140-6736(71)91915-5. [DOI] [PubMed] [Google Scholar]
  3. Bonn J. A., Turner P., Hicks D. C. Beta-adrenergic-receptor blockade with practolol in treatment of anxiety. Lancet. 1972 Apr 15;1(7755):814–815. doi: 10.1016/s0140-6736(72)90799-4. [DOI] [PubMed] [Google Scholar]
  4. Gold H. A blueprint for the expansion of human pharmacology in the medical curriculum. J Clin Pharmacol J New Drugs. 1968 Mar-Apr;8(2):74–78. doi: 10.1002/j.1552-4604.1968.tb00251.x. [DOI] [PubMed] [Google Scholar]
  5. Granville-Grossman K. L., Turner P. The effect of propranolol on anxiety. Lancet. 1966 Apr 9;1(7441):788–790. doi: 10.1016/s0140-6736(66)91863-0. [DOI] [PubMed] [Google Scholar]
  6. Jefferson J. W. Beta-adrenergic receptor blocking drugs in psychiatry. Arch Gen Psychiatry. 1974 Nov;31(5):681–691. doi: 10.1001/archpsyc.1974.01760170071012. [DOI] [PubMed] [Google Scholar]
  7. Lader M. H., Tyrer P. J. Central and peripheral effects of propranolol and sotalol in normal human subjects. Br J Pharmacol. 1972 Jul;45(3):557–560. doi: 10.1111/j.1476-5381.1972.tb08113.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Marsden C. D., Foley T. H., Owen D. A., McAllister R. G. Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci. 1967 Aug;33(1):53–65. [PubMed] [Google Scholar]
  9. Nelson J. K., McDevitt D. G. Comparative trial of propranolol and practolol in hyperthyroidism. Br J Clin Pharmacol. 1975 Oct;2(5):411–416. doi: 10.1111/j.1365-2125.1975.tb00549.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Turner P., Granville-Grossman K. L. Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Lancet. 1965 Dec 25;2(7426):1316–1318. doi: 10.1016/s0140-6736(65)92340-8. [DOI] [PubMed] [Google Scholar]
  11. Tyrer P. J., Lader M. H. Response to propranolol and diazepam in somatic and psychic anxiety. Br Med J. 1974 Apr 6;2(5909):14–16. doi: 10.1136/bmj.2.5909.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tyrer P. J. Relevance of bodily feelings in emotion. Lancet. 1973 Apr 28;1(7809):915–916. doi: 10.1016/s0140-6736(73)91365-2. [DOI] [PubMed] [Google Scholar]
  13. WILSON W. R., THEILEN E. O., FLETCHER F. W. PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM. J Clin Invest. 1964 Aug;43:1697–1703. doi: 10.1172/JCI105045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wheatley D. Comparative effects of propranolol and chlordiazepoxide in anxiety states. Br J Psychiatry. 1969 Dec;115(529):1411–1412. doi: 10.1192/bjp.115.529.1411. [DOI] [PubMed] [Google Scholar]
  15. Zaimis E. Spasticity alleviation by drugs acting directly on skeletal muscle. Lancet. 1973 Feb 24;1(7800):403–405. doi: 10.1016/s0140-6736(73)90255-9. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES